Walgreens Boots Alliance Maintains FY22 Adj. EPS Growth Outlook - Update
RTTNews
|
699 days ago
(RTTNews) - While reporting financial results for the third quarter on Thursday, retail pharmacy Walgreens Boots Alliance, Inc. (WBA) maintained its adjusted earnings growth guidance for the full-year 2022, based on year-to-date performance that is tracking broadly in line with expectations.
For fiscal 2022, the company continues to project adjusted earnings growth in the low-single digit growth.
On average, 17 analysts polled by Thomson Reuters expect the company to report earnings of $5.03 per share for the year. Analysts' estimates typically exclude special items.
read more
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March
Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews
|
86 days ago
Verrica Pharmaceuticals Announces Agreement With Walgreens To Distribute YCANTH
Dermatology therapeutics company Verrica Pharmaceuticals Inc. (VRCA) announced Wednesday the expansion of its distribution network by entering into an agreement with Walgreen Co., a subsidiary of Walgreens Boots Alliance, Inc. (WBA), to distribute YCANTH through its specialty pharmacy.
RTTNews
|
147 days ago
Walgreens Boots Alliance Guides FY24 Adj. EPS Below Estimates - Update
While reporting financial results for the fourth quarter on Thursday, Walgreens Boots Alliance, Inc. (WBA) initiated its adjusted earnings and sales guidance for the full-year 2024.
RTTNews
|
230 days ago
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products
The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews
|
259 days ago
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery
Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians. The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.
RTTNews
|
260 days ago
Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update
While reporting financial results for the third quarter on Tuesday, Walgreens Boots Alliance, Inc. (WBA) slashed its adjusted earnings guidance for the full-year 2023 to a range of $4.00 to $4.05 per share from the prior forecast range of $4.45 to $4.65 per share, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.
RTTNews
|
337 days ago
Walgreens, DoorDash, Uber Partner To Launch Free, Same Day Rx Delivery Of HIV Medications
Walgreens Boots Alliance, Inc. (WAG), in partnership with DoorDash, Inc. (DASH) and Uber Technologies, Inc. (UBER), announced Thursday free, Same Day Rx Delivery of medications for the prevention and treatment of HIV.
RTTNews
|
454 days ago
Walgreens, CVS Reportedly Plan To Offer Abortion Pills
Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. are planning to offer abortion pills after the U.S. Food and Drug Administration decided to allow retail pharmacies to sell the product in the United States, reports said. On Tuesday, the agency announced a regulatory change allowing mifepristone, which is used in first-trimester abortions, to be dispensed by retail pharmacies.
RTTNews
|
510 days ago